Literature DB >> 15507302

Role of neutralizing antibodies in PRRSV protective immunity.

O J Lopez1, F A Osorio.   

Abstract

Little has been known about the components of the immune system that are effective in the protection of a pig against PRRSV infection. Although antibodies were initially perceived as a deleterious, ineffective component of the PRRSV-specific immune response, neutralizing antibodies (NA) are now considered to be an important correlate of protective immunity against PRRSV. This paper reviews the current knowledge on arterivirus-specific NA, the role that NA have in protection against infection with PRRSV, as well as the viral molecular structures that are responsible for the production of this type of antibodies by the pig. This information should prove central to the design of new generation vaccines against PRRSV.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507302     DOI: 10.1016/j.vetimm.2004.09.005

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  103 in total

1.  The presence of alpha interferon at the time of infection alters the innate and adaptive immune responses to porcine reproductive and respiratory syndrome virus.

Authors:  Susan L Brockmeier; Crystal L Loving; Eric A Nelson; Laura C Miller; Tracy L Nicholson; Karen B Register; Marvin J Grubman; Douglas E Brough; Marcus E Kehrli
Journal:  Clin Vaccine Immunol       Date:  2012-02-01

2.  Porcine reproductive and respiratory syndrome virus neutralizing antibodies provide in vivo cross-protection to PRRSV1 and PRRSV2 viral challenge.

Authors:  Sally R Robinson; Michael C Rahe; Diem K Gray; Kyra V Martins; Michael P Murtaugh
Journal:  Virus Res       Date:  2018-02-03       Impact factor: 3.303

3.  Exosomes Mediate Intercellular Transmission of Porcine Reproductive and Respiratory Syndrome Virus.

Authors:  Ting Wang; Liurong Fang; Fuwei Zhao; Dang Wang; Shaobo Xiao
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

4.  Pathological and immunological characteristics of piglets infected experimentally with a HP-PRRSV TJ strain.

Authors:  Zhenguang Li; Yanliang He; Xiaoqin Xu; Xue Leng; Shufen Li; Yongjun Wen; Fengxue Wang; Mingqi Xia; Shipeng Cheng; Hua Wu
Journal:  BMC Vet Res       Date:  2016-10-12       Impact factor: 2.741

Review 5.  Impact of PRRSV on activation and viability of antigen presenting cells.

Authors:  Irene M Rodríguez-Gómez; Jaime Gómez-Laguna; Librado Carrasco
Journal:  World J Virol       Date:  2013-11-12

6.  Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5.

Authors:  Jung-Ah Lee; Byungjoon Kwon; Fernando A Osorio; Asit K Pattnaik; Nak-Hyung Lee; Sang-Won Lee; Seung-Yong Park; Chang-Seon Song; In-Soo Choi; Joong-Bok Lee
Journal:  Vaccine       Date:  2014-05-09       Impact factor: 3.641

7.  Genetic relationships of antibody response, viremia level, and weight gain in pigs experimentally infected with porcine reproductive and respiratory syndrome virus1.

Authors:  Andrew S Hess; Ben R Trible; Melanie K Hess; Raymond R Rowland; Joan K Lunney; Graham S Plastow; Jack C M Dekkers
Journal:  J Anim Sci       Date:  2018-09-07       Impact factor: 3.159

8.  Genome-wide transcriptional response of primary alveolar macrophages following infection with porcine reproductive and respiratory syndrome virus.

Authors:  Sem Genini; Peter L Delputte; Roberto Malinverni; Maria Cecere; Alessandra Stella; Hans J Nauwynck; Elisabetta Giuffra
Journal:  J Gen Virol       Date:  2008-10       Impact factor: 3.891

9.  The minor envelope glycoproteins GP2a and GP4 of porcine reproductive and respiratory syndrome virus interact with the receptor CD163.

Authors:  Phani B Das; Phat X Dinh; Israrul H Ansari; Marcelo de Lima; Fernando A Osorio; Asit K Pattnaik
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

10.  Functional impairment of PRRSV-specific peripheral CD3+CD8high cells.

Authors:  Sarah Costers; David J Lefebvre; Bruno Goddeeris; Peter L Delputte; Hans J Nauwynck
Journal:  Vet Res       Date:  2009-05-16       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.